Teva stock’s downward trend continues...
Teva Pharmaceutical Industries stock has continued its downward trend amid recent losses.
Analyst Ori Hershkovitz projects a 31% upside potential in the Israeli company's share price.
Teva Pharmaceutical Industries stock has continued its downward trend amid recent losses.
Analyst Ori Hershkovitz projects a 31% upside potential in the Israeli company's share price.